{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:54:51Z","timestamp":1792007691592,"version":"4.4.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Three-year Action Plan for Accelerating the Development of Traditional Chinese Medicine","award":["ZY(2018-2020)-CCCX-2002-01"],"award-info":[{"award-number":["ZY(2018-2020)-CCCX-2002-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Non-alcoholic fatty liver disease (NAFLD) with abnormal transaminase were main targeted disorder in clinical intervention. Acupuncture embedding has been used as a modified acupuncture therapy in current management, while no comprehensive summarization has been established. Hence, we conducted a systematic review and meta-analysis to evaluate the effectiveness and safety of acupoint embedding alone or in combination for NAFLD with abnormal transaminase, and to provide potential regimen for further verification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Seven English and Chinese databases were systematically researched from inception to February 28, 2019, including PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Chinese biomedical literature database (SinoMed), Chinese National Knowledge Infrastructure (CNKI), Chinese VIP information (VIP), and WanFang database. Academic dissertations were also searched as supplement. The searching terms included \u201cnonalcoholic fatty liver disease,\u201d \u201cacupoint embedding,\u201d \u201cclinical trial,\u201d with their corresponding synonyms. Randomized controlled trials (RCTs) and quasi-RCTs involving acupoint embedding alone or in combination for adult patients with NAFLD with abnormal transaminase were included. The diagnosis of NAFLD should be confirmed by radiologic evidence. Two researchers independently completed predefined data sets extraction and quality assessment. STATA 15.0 was applied to estimate the combined effect presented as odds ratio or mean difference (MD) with a 95% confidence interval (CI). The primary outcome was the change of serum alanine aminotransferase (ALT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of fifteen studies with 1349 patients were included. Meta-analysis reported that acupoint embedding alone or in combination was superior to conventional medications on ALT change (MD: 16.58, 95%CI: [10.42, 22.74], P &lt; .001). The benefits were also demonstrated in other outcomes, including aspartate aminotransferase, triglyceride, and total cholesterol, total efficacy rate and radiological efficacy rate. The safety profile of acupoint embedding was satisfactory. BL18 (Ganshu) was the most frequently utilized acupoint.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>To some extent, the systematic review supported the application of acupoint embedding in management of NAFLD, while further high-quality studies should be designed to evaluate the practical effect of acupoint embedding.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000018775","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T16:29:47Z","timestamp":1579192187000},"page":"e18775","source":"Crossref","is-referenced-by-count":8,"title":["Acupoint embedding therapy improves nonalcoholic fatty liver disease with abnormal transaminase"],"prefix":"10.1097","volume":"99","author":[{"given":"Liang","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vee Voon","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin Liver Dis"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1665-2681(19)32036-8","article-title":"Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis","volume":"5","author":"Amarapurka","year":"2006","journal-title":"Ann Hepatol"},{"key":"R6-20230915","doi-asserted-by":"crossref","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"},{"key":"R7-20230915","first-page":"641","article-title":"Guideline of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update","volume":"34","year":"2018","journal-title":"J Mod Med Health"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1463-1326.2009.01192.x","article-title":"Acupuncture: is it effective for treatment of insulin resistance?","volume":"12","author":"Liang","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/acupmed-2016-011074","article-title":"Treatment of insulin resistance by acupuncture: a review of human and animal studies","volume":"34","author":"Martinez","year":"2016","journal-title":"Acupunct Med"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"401914","DOI":"10.1155\/2015\/401914","article-title":"Acupoint catgut embedding for obesity: systematic review and meta-analysis","volume":"2015","author":"Guo","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R15-20230915","first-page":"233","article-title":"Efficacy observation of acupoint embedding combined with Shenqi Decoction for non-alcoholic steatohepatitis","volume":"13","author":"Chao","year":"2013","journal-title":"World Latest Med Inf"},{"key":"R16-20230915","first-page":"34","article-title":"Chinese Herbal Medicine combined with acupoint embedding for non-alcoholic fatty liver disease: 50 cases","volume":"46","author":"Chen","year":"2015","journal-title":"Jiangxi J Tradit Chin Med"},{"key":"R18-20230915","first-page":"1902","article-title":"Clinical study of acupoint catgut embedding therapy for non-alcoholic fatty liver","volume":"28","author":"Gong","year":"2012","journal-title":"J Pract Med"},{"key":"R19-20230915","first-page":"119","article-title":"Non-alcoholic fatty liver disease of liver stagnation and spleen deficiency pattern treated with acupoint embedding therapy: a randomized controlled trial [in Chinese]","volume":"36","author":"Huang","year":"2016","journal-title":"Zhongguo Zhen Jiu"},{"key":"R20-20230915","first-page":"272","article-title":"Clinical study of Baliao points embedding combined with Quyuhuazhuo Decoction for non-alcoholic steatohepatitis","volume":"26","author":"Huang","year":"2017","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"R21-20230915","first-page":"637","article-title":"Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis [in Chinese]","volume":"30","author":"Liu","year":"2010","journal-title":"Zhongguo Zhen Jiu"},{"key":"R23-20230915","first-page":"76","article-title":"The therapeutic effect observation of point embedding therapy in treating nonalcoholic fatty liver disease","volume":"7","author":"Xu","year":"2015","journal-title":"Clin J Chin Med"},{"key":"R26-20230915","first-page":"40","article-title":"Effects of catgut implantation on skin temperature of acupuncture point of foot three yin meridians with nonalcoholic fatty liver disease","volume":"15","author":"Zhou","year":"2011","journal-title":"J Clin Med Pract"},{"key":"R27-20230915","first-page":"58","article-title":"Effect of catgut implantation on serum leptin and insulin resistance of nonalcoholic fatty liver disease","volume":"14","author":"Zhou","year":"2012","journal-title":"J Liaoning Univ TCM"},{"key":"R28-20230915","first-page":"1845","article-title":"Effect of acupoint catgut embedding and Qiangganxiaozhi Decoction on serum leptin and insulin resistance of nonalcoholic fatty liver disease","volume":"19","author":"Zhou","year":"2010","journal-title":"J Emerg Tradit Chin Med"},{"key":"R29-20230915","first-page":"161","article-title":"Clinical efficacy observation of acupoint embedding for abdominal obesity combined with non-alcoholic fatty liver","volume":"36","author":"Zhou","year":"2017","journal-title":"Nei Mongol J Tradit Chin Med"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11655-015-2088-3","article-title":"Somato stimulation and acupuncture therapy","volume":"22","author":"Zhao","year":"2016","journal-title":"Chin J Integr Med"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00207450500341472","article-title":"The mechanism of acupuncture and clinical applications","volume":"116","author":"Cabyoglu","year":"2006","journal-title":"Int J Neurosci"},{"key":"R32-20230915","first-page":"1251","article-title":"Research status of the effect mechanism on catgut-point embedding therapy [in Chinese]","volume":"37","author":"Huo","year":"2017","journal-title":"Zhongguo Zhen Jiu"},{"key":"R33-20230915","first-page":"82","article-title":"Different regulative effects on LPL and HL of hyperlipemia rat model by acupuncture on Fenglong(ST.40) acupoint and combination of acupoints","volume":"26","author":"Nong","year":"2008","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R34-20230915","first-page":"847","article-title":"Impact of electro-acupuncture on lipid metabolism in rats with non-alcoholic fatty liver disease","volume":"43","author":"Zhu","year":"2012","journal-title":"J Sichuan Univ (Med Sci Edi)"},{"key":"R35-20230915","first-page":"277","article-title":"Effect of electroacupuncture on hypothalamic leptin and leptin receptor mRNA expression in rats with nonalcoholic fatty liver disease [in Chinese]","volume":"35","author":"Bai","year":"2010","journal-title":"Zhongguo Zhen Jiu"},{"key":"R36-20230915","first-page":"602","article-title":"Influence of electroacupuncture intervention in serum RBP4 level in rats with non-alcoholic fatty liver disease and its lipid regulation mechanism","volume":"40","author":"Jiang","year":"2014","journal-title":"J Jilin Univ (Med Edit)"},{"key":"R37-20230915","first-page":"345","article-title":"Effects of electroacupunctrue combined with dietary control on peroxisome proliferator-activated receptor-, and liver fatty acid-binding protein levels in non-alcoholic fatty liver disease rats [in Chinese]","volume":"40","author":"Zhang","year":"2015","journal-title":"Zhen Ci Yan Jiu"},{"key":"R38-20230915","first-page":"99","article-title":"Influence of electroacupuncture intervention on serum retinol binding protein 4 and liver function in nonalcoholic fatty liver rats [in Chinese]","volume":"37","author":"Zhu","year":"2012","journal-title":"Zhen Ci Yan Jiu"},{"key":"R39-20230915","first-page":"1055","article-title":"Electroacupuncture treats rat non-alcoholic fatty liver by blocking insulin resistance and peroxidation","volume":"30","author":"Zeng","year":"2008","journal-title":"Acta Acad Med Mil Tertiae"},{"key":"R40-20230915","first-page":"111","article-title":"Influence of electroacupuncture on insulin-resistanee in nonalcoholic fatty liver rats [in Chinese]","volume":"33","author":"Feng","year":"2008","journal-title":"Zhen Ci Yan Jiu"},{"key":"R41-20230915","first-page":"89","article-title":"Influence of electroacupuncture on hepatic cytochrome P4501A1 expression and lipid peroxidation in nonalcoholic fatty liver rats [in Chinese]","volume":"34","author":"Feng","year":"2009","journal-title":"Zhen Ci Yan Jiu"},{"key":"R42-20230915","first-page":"208","article-title":"Influence of electroacupuncture stimulation on serum and hepatic interleukin-18 expression in nonalcoholic fatty liver rats [in Chinese]","volume":"38","author":"Wang","year":"2013","journal-title":"Zhen Ci Yan Jiu"},{"key":"R43-20230915","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11655-016-2451-z","article-title":"Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China","volume":"23","author":"Lu","year":"2017","journal-title":"Chin J Integr Med"},{"key":"R44-20230915","doi-asserted-by":"crossref","first-page":"e0147244","DOI":"10.1371\/journal.pone.0147244","article-title":"Do the CONSORT and STRICTA checklists improve the reporting quality of acupuncture and moxibustion randomized controlled trials published in Chinese journals? A systematic review and analysis of trends","volume":"11","author":"Ma","year":"2016","journal-title":"PLoS One"},{"key":"R46-20230915","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11655-018-2999-x","article-title":"Standard protocol items for clinical trials with traditional Chinese medicine 2018: recommendations, explanation and elaboration (SPIRIT-TCM Extension 2018)","volume":"25","author":"Dai","year":"2019","journal-title":"Chin J Integr Med"},{"key":"R47-20230915","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/aim.2009.001370","article-title":"Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement","volume":"28","author":"MacPherson","year":"2010","journal-title":"Acupunct Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:19:05Z","timestamp":1694819945000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018775"}},"subtitle":["A PRISMA-compliant systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018775","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}